Czechia· CZ-0193808
BEXSERO
A meningokokkus b, multikomponenten-impfstoff product containing neisseria meningitidis group b nhba fusion protein + neisseria meningitidis group b nada protein + neisseria meningitidis group b fhbp fusion protein + outer membrane vesicles from neisseria meningitidis group b (strain nz98/254), registered in Czechia by GSK Vaccines S.r.L, Siena. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Meningokokkus b, multikomponenten-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC J07AH09 (meningokokkus b, multikomponenten-impfstoff), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Meningokokkus b, multikomponenten-impfstoff · ATC J07AH09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN + NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN + NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN + OUTER MEMBRANE VESICLES FROM NEISSERIA MENINGITIDIS GROUP B (STRAIN NZ98/254)
- Manufacturer
- GSK Vaccines S.r.L, Siena
- Country
- Czechia (CZ)
- ATC code
- J07AH09
- ATC class
- Meningokokkus B, Multikomponenten-Impfstoff
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH09
Meningokokkus b, multikomponenten-impfstoff, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f178b381-9bcd-4fb5-8638-9dbfa98b406d GET /v1/drugs/f178b381-9bcd-4fb5-8638-9dbfa98b406d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SUS ISP",
"source": "sukl",
"strength": null,
"pack_size": "10X0,5ML",
"substance": "NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN + NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN + NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN + OUTER MEMBRANE VESICLES FROM NEISSERIA MENINGITIDIS GROUP B (STRAIN NZ98/254)",
"cz_kod_sukl": "0193808",
"product_type": "IM",
"substance_codes": "21059,21060,21061,21062",
"registration_state": "R",
"registration_number": "EU/1/12/812/004"
}See everything about meningokokkus b, multikomponenten-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.